SRY and central nervous system cancer: SRY (sex determining region Y)‐box 2 (SOX2) is revealed as a stemness marker in glioma 19 and a transcription factor highly associated with pluripotency.20 Current study investigated the relationship between SOX2 and miR‐129 to further elucidate the molecule network of miR‐129 in glioma stem cells progression.